P2c Pharma Ltd
11485980
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 26/07/2018
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 49
Also on 1 other board
Persons with Significant Control
Dr Mark Henry Saunders
British · England · Age 49
Starcourt, Thames Street, Reading, RG4 6UR
Notified 26/07/2018
CompanyRankvs 87765+ SIC 70229 peers74
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Turnover
£413k
Annual revenue
Net Worth
£987k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£1.1M
Working capital
Current Assets
£1.0M
Current Liabilities
£0
Fixed Assets
£0
Profit After Tax
£238k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | Infinity | +£174k |
| 2024 | Infinity | +£24k |
| 2023 | Infinity | +£308k |
| 2022 | Infinity | +£251k |
| 2021 | Infinity | +£165k |
| 2020 | Infinity | — |
| 2019 | Infinity | — |
Derived from filed accounts. Not audited figures.